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Glucagon stimulates chloride transport independently of cyclic
AMP in the rat medullary TAL
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Division of Nephrology, Department of Medicine, Jichi Medical School, Minamikawachi, Kawachi, Tochigi 329-04, Japan
Glucagon sthnulates chloride transport independently of cyclic AMP in
the rat medullary TAL. The effect of glucagon on chloride transport was
studied in the rat medullary thick ascending limb (MTAL) perfused in
vitro. In the bath, 10—6 58 glucagon increased the effiux coefficient of Cl
(Ke1) from 6.88 0.21 x lO to 9.65 0.38 x lO cm sec (P <
0.01) without changing the influx coefficient (Kic1; 2.87 0.54 x iO in
control vs. 2.83 0.57 x i0 cm sec with glucagon) or transepi-
thelial potential difference (4.8 0.76 in control vs. 5.0 0.71 mV with
glucagon). A physiological concentration of glucagon (10—8, 10_to M)
also increased chloride effiux significantly. Pretreatment of tubules with
luminal furosemide (10 M) and/or basolateral ouabain (l0 M)
completely abolished the effect of glucagon. In isolated MTALs incu-
bated in the same medium as that used in the microperfusion study,
10—6 54 glucagon stimulated cAMP production by 255.2 33.7% (P <
0.01). However, neither dibutyryl cAMP (l0—, lO M) nor forskolin
(l0, 10—6 M) increased the chloride effiux. It is concluded that: 1)
Glucagon stimulates net Cl reabsorption by increasing Cl effiux in the
rat MTAL; and 2) cyclic AMP is not responsible for this effect of
glucagon.
It is now well known that the medullary thick ascending limb
of the loop of Henle (MTAL) is a common target site of certain
peptide hormones, such as calcitonin, glucagon, parathyroid
hormone and vasopressin [1, 2]. All of these hormones stimu-
late cyclic AMP (cAMP) generation in this segment by activat-
ing adenylate cyclase [2]. In vivo micropuncture studies using
hormone-deprived Brattleboro rats have shown that these four
hormones exert similar effects on Ca, Mg and K transport in the
loop segment of the superficial nephron [3—5]. Accordingly, it
has been postulated that these hormonal actions on electrolytes
transport in the MTAL are mediated by a common second
messenger, cAMP [2]. However, as it is very difficult to
specifically estimate the action of cAMP in the MTAL by in
vivo micropuncture, there is still insufficient evidence support-
ing this hypothesis. In the isolated mouse MTAL perfused in
vitro, vasopressin increases transepithelial potential difference
(Vt) and chloride effiux [6—9]. Cyclic AMP is known to mediate
these vasopressin actions [7, 10, 11] in the mouse MTAL.
Glucagon, as well as vasopressin, increases Vt [9, 12] in this
segment in the mouse. Thus in the mouse MTAL, both vaso-
pressin and glucagon are thought to exert similar effects on Vt
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and Cl transport via a cAMP-mediated signal transduction
pathway [9, 12, 13]. On the other hand, in the rat MTAL,
although a significant stimulation in cAMP generation by vaso-
pressin has been consistently observed [2, 8], any change in Vt
induced by vasopressin is either absent [8] or very small [14].
Even a supramaximal dose (l0 M) of chlorophenylthio-
cAMP, which is the most permeative and phosphodiesterase-
resistant cAMP analogue [15], produces only a minimal Vt
change in the rat MTAL [14], while in the mouse MTAL, a low
dose (10k M) of a less potent cAMP analogue (dibutyryl cAMP)
causes a clear increase in Vt [9]. This species difference
observed in the mouse and the rat MTAL is not due to a
difference in the adenylate cyclase response to vasopressin or a
difference in cAMP-phosphodiesterase activity [8]. The action
of other peptide hormones, such as calcitonin and parathyroid
hormone, has not yet been fully examined in the isolated
perfused rat MTAL. Thus the original hypothesis that multiple
peptide hormones modulate ion transport via a cAMP-depen-
dent mechanism has not been totally confirmed in the rat
MTAL. The present studies were conducted to explore the
effect of glucagon on Cl transport in the rat MTAL and to
evaluate the role of cAMP in Cl transport. It was found that
glucagon exerted cAMP-independent stimulation of Cl efflux.
Methods
In vitro microperfusion of isolated renal tubules
Male Sprague-Dawley rats weighing 100 to 300 g, which had
been allowed free access to food and water prior to the
experiments were used. Both kidneys were removed from
anesthetized (50 mg/kg body wt pentobarbital, i.p.) animals and
1 to 2 mm-thick slices were prepared. MTALs were isolated
with fine forceps in chilled dissection medium under stereomi-
croscopic observation. The isolated MTALs were transferred
to a 1.0 ml bath chamber on the stage of an inverted micro-
scope. Each tubule was cannulated and perfused with concen-
tric micropipettes according to the method of Burg et al [16]
with minor modifications [17]. An artificial solution simulating
serum ultrafiltrate was used as the dissection medium, bathing
medium, and perfusate. The composition of these media was as
follows (mmol): NaCI 110, NaHCO3 25, Na2HPO4 1.6,
NaH2PO4 0.4, KC1 5, MgC12 1.0, CaCl 1.8, Na acetate 10,
glucose 8.3, L-alanine 5.0 (osmolarity 296 mOsm). For the
dissection and bathing media, 5% vollvol rabbit serum was
added instead of glucose and alanine [18]. The perfusate con-
tained 0.2 mg/ml food, drug and cosmetic green dye (FD&C
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dye) to detect cell damage and perfusate leakage. Before use, all
solutions were bubbled with a 95% 02/5% CO2 gas mixture for
more than 60 minutes, and the pH was adjusted to 7.4. During
the experiment, the bathing medium was continuously bubbled
with the same gas mixture, and the bath temperature was kept
themostatically at 37°C.
The perfusion rate was adjusted to approximately 10 nl/min
using hydrostatic pressure. The perfused fluid was collected in
a constriction volume pipette of a known volume (between 60
and 70 nl). The Vt was continuously monitored during the
experiment as described previously [18]. Collections were
started when Vt became stable after 10 to 20 minutes of
equilibration.
Calculations
In Cl effiux studies, Na36C1 (New England Nuclear, Boston,
Massachusetts, USA) was added to the perfusate. Lumen-
to-bath Cl efflux (Jec1, pEq mm' sec') and the effiux
coefficient of Cl (Ke1, cm sec 1) were calculated from the
disappearance rate of 36C1 according to the following equations
[18]:
Jec1=[Cl]ViL''(l—Co'Ci')
Ke1 = Vi A' Ln(Ci Co)
where [Cl] is the Cl concentration of the perfusate, Vi is the
perfusion rate, L is the tubule length measured directly by an
eyepiece reticule at the end of each experiment, Co and Ci are
the respective radioactivity levels of 36C1 (cpm per nl) in the
collected fluid and perfusate, and A is the inner surface area of
the perfused tubule calculated using L and an assumed lumen
diameter of 20 sm.
In Cl influx studies, 36C1 was added to the bath medium. The
influx coefficient of Cl (KiD, cm sec') was calculated from the
appearance rate of 36Cl in the collected fluid as follows [18, 19]:
Ki1 = mKe1 Co Cb . [1 — e(_m A Vj)1-I (3)
where mKe1 is the mean value of Ke1 obtained in effiux
studies, and Cb is the radioactivity level of 36C1 in the bathing
medium (cpm per nl).
Mean net Cl flux (mJn1, pEq mm sec I) was calculated
as follows [18, 20]:
mJn1 = mVi [Cl] . [1 — [mKe1 — mKic1)
emKeD mA mVi) + mKi1] . mKe] L'
where mVi and mA are the means of individual Vi and A in the
both efilux and influx studies, and mKe1 and mKi1 are the
means of individual Ke1 and Ki1, respectively.
The radioactivity of 36Cl was counted using a liquid scintil-
lation counter (LSC-671, Aloka, Tokyo, Japan).
Experimental protocols
In preliminary time-control experiments, Vt, Je1 and Ke1
were stable for at least 90 minutes after the equilibration period.
Therefore all experiments were designed to be completed
within 75 minutes. During all experiments, 20 d volumes of
distilled water were added to the bath at five minute intervals to
prevent any change in osmolarity of the bathing medium due to
evaporation. Stability of the osmolarity was confirmed in a
preliminary study, in which the radioactivity of the 36Cl-
containing bathing medium was measured intermittently under
the same experimental conditions as described below. In each
experimental period, three collections were made to calculate
the mean value of each parameter. The time required for each
individual collection was about six to seven minutes.
1. Effects of glucagon on Cl transport and Vt. Effiux and
influx studies were conducted using separate groups of tubules.
After control period collections, 10—6 M glucagon was added to
the bath. This concentration was chosen to facilitate compari-
son of data with those previously reported [9, 12, 21], During
the experimental period, collections were started 5 to 10 min-
utes after the addition of glucagon. Recovery period collections
were started 5 to 10 minutes after the removal of glucagon by
totally exchanging the bathing medium.
2. Dose dependency of the glucagon effect on Cl efflux. The
effect of physiological (l0 10 M) and supraphysiological (10_8
M) doses of glucagon on Cl efflux was examined. Since the
effect of glucagon disappeared rapidly after its removal in
protocol 1, dose-response experiments were performed without
a recovery period. After control collections, 10_b M glucagon
was added to the bath and the first experimental collections
(1) were made after 5 to 10 minutes. Subsequently, the bathing
(2) medium was totally exchanged and collections in the second
experimental period were started 5 to 10 minutes after the
addition of 108 M glucagon.
3. Effect of furosemide on glucagon action. Tubules were
pretreated with luminal furosemide (l0 M) alone, or with
luminal furosemide and bath ouabain (l0 M). The control and
experimental period collections were made in the same manner
as for protocol 1.
4. Effect of dibutyryl cyclic AMP (DcAMP) and forskolin on
Cl efflux. This protocol was designed to examine whether
cAMP mediates the action of glucagon. In the DcAMP experi-
ment, i0 M DcAMP was added to the bath after the control
collections. A volume of lO_6 M glucagon was superimposed on
DcAMP instead of a recovery period. Either DcAMP (10—i or
iO M) or forskolin (10—a or 10—6 M) was added to the bath
after the control collections without recovery collections. The
forskolin was dissolved in pure ethanol and the final concentra-
tion of ethanol in the bath was 0.5% vollvol. An identical
amount of ethanol was present during the control period.
Microassay of cAMP generation in isolated MTAL
The effect of glucagon on cAMP generation in the rat MTAL
was examined using the method described by Morel et al [2]
with modifications [22]. Male Sprague-Dawley rats, weighing
200 to 300 g were anesthetized (50 mg/kg body wt pentobarbital,
i.p.). The abdominal aorta was cannulated in a retrograde
manner with a polyethylene tube (PE-100, Clay Adams, Parsip-
pany, New Jersey, USA) and the tip was placed just distal to
the orifice of the left renal artery. The left kidney was perfused
with 5 to 10 ml of chilled modified Hank's solution (in mM: NaCI
135, KCI 5, CaCl2 1.0, MgC12 1.0, MgSO4 0.8, Na2HPO4 0.33,
Tris-HC1 10, pH 7.4) containing 0.1% wt/vol bovine serum
albumin (Reheis Chemical, Phoenix, Arizona, USA) and sub-
sequently with 15 ml of chilled collagenase medium for five
minutes. The collagenase medium was modified Hank's solu-
tion containing 0.1% wt/vol collagenase (type I, 150 U/mg,
Sigma) and 0.1% wt/vol bovine serum albumin. The left kidney
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Table 1. Effect of various agents on chloride effiux in the rat MTAL
N
PD
mV
Flux coefficient
x 1O cm/sec
C
Vi
ni/mm
E R
TL
mmC E R C E R
Influx coefficient (1(1)
Glucagon l0 M
5 3.4 0.7 4.0 1.0 4.2 0.9 2.87 0.58 2.83 0.61 2.53 0.93 9.8 10.0 10.3 0.41
Effiux coefficient (Ke)
Glucagon 10—6 M
6 5.7 1.2 5.4 1.1 4.2 0.8 6.88 0.29 9.65 0.38a 7.65 0.38 11.7 12.2 14.5 0.34
Furosemide 10 as
& ouabain iO M
7 1.8 0.6 3.1 0.8 3.09 0.23 2.60 0.15 11.7 11.9 0.36
Dc-AMP i0 M &
glucagon 10—6 M
7 4.1 0.8 4.2 0.8 4.1 0.8 10.19 1.22 10.29 1.47 13.19 1.59 11.1 10.9 10.3 0.40
Dc-AMP iO M
5 3.1 0,8 3.8 1.0 8.75 1.79 9.35 1.85 10.4 10.4 0.40
Forskolin lO &
10_6 M
8 2.9 0.2 3.1 0.3 7.8 0.78 7.24 0.72 10.7 10.8 0.40
N denotes number of tubules used in each experiment. Tubule length (TL) and perfusion rate (Vi) were not significantly different among the
experiments, thus only mean values were listed in the Table. In the experiments of l0 si DcAMP, 10—6 M glucagon was superimposed during
the recovery period.
a P < 0.01 vs. control.
was quickly removed and 1 to 2 mm-thick coronal slices were
prepared. The slices were incubated in aerated collagenase
medium at 35°C for 30 to 45 minutes. They were then rinsed
thoroughly in cold dissection medium and transferred to a Petri
dish containing ice-cold dissection medium. Isolated MTALs
were transferred to small glass coverslips and their lengths were
measured using a microscope with a calibrated drawing attach-
ment (Stereophoto SMZ, Nikon, Tokyo, Japan). The total
length of the tubules on one coverslip ranged from 3.5 to 7.0
mm. Tubules were then incubated with or without 10—6 M
glucagon. The incubation medium was identical to the dissec-
tion medium except for the addition of 5 x i0 M 1-methyl-
3-isobutyl-xanthine (Aldrich Chemical, Milwaukee, Wisconsin,
USA). To study the effect of glucagon on cAMP generation
under conditions similar to those in the microperfusion study,
the bathing medium used in the microperfusion study was also
employed for these experiments as both the dissection and
incubation media. Likewise, the temperature (37°C) and the
incubation time (15 mm) were comparable to those of the
microperfusion study. Incubation was stopped by placing the
glass slips on a block of dry ice. The amount of cAMP generated
was measured using a radioimmunoassay kit (Yamasa, Choshi,
Japan).
Reagents
Highly purified glucagon was purchased from Novo (Copen-
hagen, Denmark). Furosemide was purchased from Hoechst
Japan (Tokyo, Japan). DcAMP, forskolin, and ouabain were
purchased from Sigma (St. Louis, Missouri, USA).
Statistics
Data are presented as means SE. Statistical comparisons
were made using Student's 1-test. Differences at P < 0.05 were
considered statistically significant.
Results
In vitro microperfusion of isolated MTAL
1. Effects of glucagon on Ci transport and Vt. As shown in
Table 1 and Figure 1, 10_6 M glucagon increased Ke1 (xlO'5
cm sec') from 6.88 0.29 to 9.65 0.38 (P < 0.01).
Subsequent removal of glucagon decreased the Ke1 to 7.65
0.38 x 1O cm sec' (P < 0.01). In contrast, glucagon had no
effect on Ki1 (Fig. 2). Accordingly, the calculated mJn1 was
increased from 3.66 to 6.63 pEq . mm sec. In the control
period of the efflux study, Vt was 5.7 1.2 mY, which was
similar to values reported previously [8, 9]. Glucagon had no
significant effect on Vt (Table 1). Although five additional
experiments were conducted to examine exclusively the effect
on Vt under free-flow conditions, no change in voltage was
observed (Fig. 3).
2. Dose dependency of the glucagon effect on Cl efflux. Four
experiments were conducted to examine the effect of lower
doses of glucagon (Fig. 4). A physiological concentration of
glucagon (10b0 M) increased Ke1 (xl0 cm sec') from
5.44 0.32 to 6.16 0.26 (P < 0.02). Subsequent addition of
10—8 M glucagon further increased Ke1 to 8.03 0.86 )< 10
cm sec' (P < 0.05 vs. control). Percentage increases in Ke1
(%Ke1; [experimental Ke1 — control Ke1] . controlKe1' . 100) produced by l0_6 M, l0— M, and 10b0 M
glucagon were calculated to be 42.1 9.6, 47.3 11.7, and 13.8
3.1%, respectively.
3. Effect of furosemide on glucagon action. During the
control period, luminal application of furosemide with (N = 3)
or without basolateral ouabain (N = 4) suppressed Ke1 and Vt.
Since the suppression by furosemide alone was as potent as that
by furosemide with ouabain, data from both groups are shown
together (Table 1, Fig. 5). Je1 was also suppressed to 2.93
0.19 pEq mm' sec'. Using the mKi1 in protocol 1, mJn1
ax
a,
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Fig. 1. Effect of glucagon on Cl efflux in rat MTAL. Lumen-to-bath Cl
effiux coefficient (Ke,) was measured in terms of the rate of disappear-
ance of 36C1 from the perfusate, After the control collection (C), 106 M
glucagon was added to the bathing medium (G). Glucagon increased
Ke1 significantly (P <0.01 vs. control). Ten minutes after completely
rinsing the bath medium, recovery collection was performed (R).
was calculated to be 0.11 pEq mmt . sec, whereas
mJn1 in the absence of furosemide or ouabain was 3.66
pEq mm sec in protocol 1. These data demonstrated
that net active transcellular CI transport was almost completely
abolished by luminal furosemide with or without basolateral
ouabain in the control period. Pretreatment with these agents
also completely abolished the effect of superimposed glucagon
on Cl transport (Table 1, Fig. 5).
4. Effect of dibutyryl cyclic AMP (DcAMP) and forskolin on
Cl efflux. Neither DcAMP (10 M, i0 M) nor forskolin (l0—
M, 10 M) produced a significant change in Vt or Ke1 (Table
1, Fig. 6, 7). In experiments where glucagon was superimposed
on 10 M DcAMP (Fig. 6), although there was no effect of
DcAMP on Ke1 (10.19 1.22 x l0— cm sec in the control
and 10.29 1.47 cm sec by DcAMP, respectively), super-
imposed glucagon increased Ke1 significantly (13.19 1.59, P
<0.01 vs. DcAMP).
Microassay of cAMP generation in isolated MTAL
Under a condition similar to those of the microperfusion
studies, 10 M glucagon stimulated cAMP generation (fmoll
mm tubule length per 15 mm) from a control value of 0.42
0.04 to 1.04 0.14 (255.2 23.7% increase, P <0.01) as shown
in Figure 8.
_____ Fig. 2. Effect of glucagon on Cl influx in rat MTAL. Influx coefficient
R ofCl was measured in terms of the rate of appearance of 36C1 in the
perfusate. Bath glucagon (106 M) had no effect on Ki1.
Discussion
It is well established in the rat that glucagon specifically binds
to MTAL [1] and stimulates cAMP generation by activating
adenylate cyclase [2, 21, 23]. It has also been observed, using in
vivo micropuncture of rat kidney, that systemic administration
of glucagon increases fractional reabsorption of Ca, Mg and K
in Henle's loop of superficial nephrons in the rat kidney [3]. The
direct effect of glucagon on MTAL, however, has not been well
investigated.
On the other hand, another polypeptide hormone, vasopres-
sin, has been found to increase Cl transport and Vt in the
isolated mouse MTAL perfused in vitro [6—9]. Cyclic AMP is
known to mediate this effect because the actions of vasopressin
can been reproduced by administration of cAMP analogues in
the mouse MTAL [6, 24]. Since glucagon also stimulates cAMP
generation and causes a change in Vt similar to that produced
by vasopressin in the mouse MTAL [9, 12], it has been assumed
that glucagon stimulates Cl transport via cAMP [9, 12]. How-
ever, there is a marked species difference in the response of
MTAL to vasopressin. In the mouse MTAL, the effect of
vasopressin on both Vt and Cl transport are well demonstrated
and it is established that these vasopressin actions are mediated
by cAMP [7, 11]. In the MTALs of Sprague-Dawley rats and
rabbits, however, the change in Vt produced by vasopressin is
absent or insignificant [8, 25]. In the rabbit MTAL, this lack of
vasopressin effect is explainable by a lower activity of vaso-
pressin-sensitive adenylate cyclase in comparison with that of
the mouse MTAL [26]. However, in the rat MTAL, the activity
of this enzyme is as high as that in the mouse MTAL [8]. It also
seems unlikely that a difference in cAMP-phosphodiesterase
activity would explain the lack of a vasopressin effect on Vt in
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the rat MTAL, because simultaneous administration of a phos-
phodiesterase inhibitor with vasopressin in the rat MTAL failed
to affect Vt [8]. Furthermore, a very high concentration (10—s
M) of chlorophenylthio-cAMP, which is the most permeative
and phosphodiesterase-resistant agent among several cAMP
analogues [15], produces only a minimal change in Vt in the
MTAL of the Brattleboro rat [14], whereas in the mouse
MTAL, a lower dose (10 M) of a less potent cAMP analogue,
DcAMP, causes a marked increase in Vt [9]. Therefore, al-
though it is generally accepted that some peptide hormones
(calcitonin, glucagon, parathyroid hormone and vasopressin)
exert similar effects on ion transport in the MTAL by stimulat-
ing cAMP generation [2—5], there is no direct evidence for this
phenomenon in the rat MTAL, the segment for which this
hypothesis was originally postulated [2].
Our present data demonstrated that glucagon, even at phys-
iological concentrations, stimulates net Cl reabsorption in the
rat MTAL by increasing the lumen-to-bath Cl efflux without any
change in the bath-to-lumen Cl influx (Table 1, Figs. 1, 2, 4). It
is most likely that the increment of Cl efflux is related to
stimulation of the furosemide sensitive cotransport system on
the apical membrane (Na:K:2Cl electroneutral cotransport and!
or Na:H, C1:HCO3 antiport system) [13] because this efflux was
completely abolished by luminal furosemide (Table 1, Fig. 5).
However, we are unable to determine whether glucagon di-
rectly stimulates this apical cotransport, since glucagon may
also primarily stimulate basolateral Cl exit [24].
In agreement with the results obtained by others for the rat
MTAL [21], glucagon stimulated cAMP generation in our study
(Fig. 8). Nevertheless, neither DcAMP nor forskolin was able
to mimic the effect of glucagon on Cl transport (Table 1, Figs. 6,
7). These results argue against the hypothesis that cAMP
mediates the effect of glucagon on Cl transport in the rat
MTAL. Recently various peptide hormones including glucagon
[27, 281 have been found to stimulate the phosphoinositide (P1)
breakdown-initiated signal transduction pathways [29], that is,
the calcium-mediated pathway and the protein kinase C path-
way [30]. This system is known to regulate the functions of
various tissues and cells [31—33] including renal tubules [34]. In
hepatocytes, the effects of glucagon on glycogenolysis and
gluconeogenesis can be mediated either by the cAMP pathway
or by P1 breakdown [27, 32]. Thus the effects of glucagon on its
target cells are not necessarily mediated by cAMP. In isolated
MTAL cells, a protein kinase C activator [35], phorbol my-
ristate acetate, has been reported to stimulate K uptake [36].
Further study will be required to address the role of the P1
breakdown cascade in mediating the effect of glucagon on Cl
transport in the rat MTAL.
The lack of the change in Vt (Fig. 3) after addition of glucagon
is somewhat puzzling. In the mouse MTAL, it is well estab-
lished that there is a tight correlation between Vt and vaso-
pressin-stimulated net Cl transport [7, 11, 37]. At present we
have no data to explain the discrepancy between the change in
Vt and Cl transport observed in our study. Since transcellular
Cl transport in this nephron segment is suggested to be associ-
ated with many electroneutral or electrogenic ion transport
NS NS10 10
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Fig. 3. Effect of glucagon on transepithelial potential dUference (Vt) in
rat MTAL. In addition to the experiment using protocols 1 and 2, 5
tubules were perfused under a free-flow condition. Glucagon at 106 M
had no effect on Vt.
1010M 108MC
Glucagon
Fig. 4. Effect of lower doses of glucagon on Cl efflux in the MTAL. A
physiological concentration (10_b M) and a supraphysiological concen-
tration (108 M) of glucagon also increased Ke1 significantly.
Ando et a!: Glucagon increases Cl efflux 765
6 15
NS
q)
E
4 i 10
x
x
0
2
NS I L..____ P < 0.01
C G
Fig. 5. Effect of luminal furosemide with or without basolateral oua-
bain on the effect ofglucagon. Luminal furosemide iO Malone (•) or
luminal furosemide lO M with basolateral ouabain l0 M (0) de-
creased Ke1 in the control period and completely abolished the effect
of superimposed glucagon on Cl efflux.
processes in both the apical and basolateral membranes [16,
37], it is impossible to determine the mechanism of glucagon-
stimulated Cl transport without conducting more detailed elec-
trophysiological studies. However, the correlation between Vt
and net Cl transport has been proven to be valid only in the
mouse MTAL, in which vasopressin exerts its effect via cAMP
generation. Furthermore, this observation was done only when
a change in Vt was observed upon administration of vasopres-
sin. In the Brattleboro rat, Cl flux is increased by vasopressin in
MTAL with Vt change, but this voltage change seems to be
minimal comparing with the change of Cl flux [38]. Thus the
possibility that these hormones stimulate Cl transport without
affecting Vt is still totally unexplored. From our present data, it
appears that the mechanism of glucagon-stimulated Cl transport
in the rat MTAL is different from that of vasopres sin-stimulated
and cAMP-mediated Cl transport in the mouse MTAL.
In summary, the present study has demonstrated that gluca-
gon stimulates net Cl reabsorption by increasing the lumen-
to-bath efflux in the rat MTAL. This stimulation occurs at
physiological concentrations of glucagon, and is dependent on
furosemide-inhibitable apical Cl transport. In contrast to the
actions of vasopressin in the mouse MTAL, the effect of
glucagon on Cl transport is not mediated by cAMP.
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